Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Lenalidomide is efficient in reducing red blood cell transfusion dependency and markedly lowering platelet counts in MDS/MPN-RS-T in the context of major platelet counts.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7495870PMC
http://dx.doi.org/10.1002/ccr3.3026DOI Listing

Publication Analysis

Top Keywords

platelet counts
8
efficacy lenalidomide
4
lenalidomide myelodysplastic/myeloproliferative
4
myelodysplastic/myeloproliferative neoplasms
4
neoplasms ring
4
ring sideroblasts
4
sideroblasts extreme
4
extreme platelet
4
platelet count
4
count lenalidomide
4

Similar Publications

Objectives: The Charlson comorbidity index reflects overall comorbidity burden and has been applied in cardiovascular medicine. However, its role in predicting in-hospital mortality in patients with acute myocardial infarction (AMI) complicated by ventricular arrhythmias (VA) remains unclear. This study aims to evaluate the predictive value of the Charlson comorbidity index in this setting and to construct a nomogram model for early risk identification and individualized management to improve outcomes.

View Article and Find Full Text PDF

Reply to letter: 'Revisiting the role of percutaneous coronary intervention in acute coronary syndrome with elevated platelet count: A constructive perspective'.

Arch Cardiovasc Dis

August 2025

Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, No. 2 Anzhen Road, Chaoyang District, Beijing 100029, China. Electronic address:

View Article and Find Full Text PDF

Evaluation of different platelet-dependent von Willebrand factor activity assays to assess the in vivo inhibitory effect of caplacizumab on the von Willebrand factor-platelet interaction.

J Thromb Haemost

September 2025

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy. Electronic address:

Background: Caplacizumab, a humanized anti-von Willebrand Factor (VWF) Nanobody®, is employed for immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP) treatment. Its binding to the VWF A1 domain sterically inhibits VWF interaction with platelet glycoprotein Ib (GPIb), counteracting microthrombosis and accelerating the normalization of the platelet count. In caplacizumab-treated iTTP patients with bleeding episodes, measuring platelet-dependent VWF activity (VWF activity) is crucial for monitoring treatment with VWF concentrates.

View Article and Find Full Text PDF

The hidden connection: systemic immune-inflammation index and its role in asthma.

Clinics (Sao Paulo)

September 2025

School of Integrated Traditional Chinese and Western Medicine, Anhui University of Chinese Medicine, China. Electronic address:

Background: This study explores potential associations between asthma and the Systemic Immune-Inflammation Index (SII).

Methods: The study primarily focuses on adults with complete data on SII and asthma from the National Health and Nutrition Examination Survey database (2015-2020). SII is calculated using the formula: platelet count × neutrophil count / lymphocyte count.

View Article and Find Full Text PDF

The relationship between dietary biotin intake and cognitive function remains unclear. This study explores the association between biotin and dementia, and the mediating role of inflammation indicators. Dietary biotin intake was assessed via the 24-h recall questionnaire.

View Article and Find Full Text PDF